Analysis of Olaparib Response in Patients With BRCA1 and/or 2 Promoter Methylation Diagnosed of Advanced Breast Cancer
Clinical trial NCT03205761 · COMPLETED
Trial details
- NCT number
- NCT03205761
- Sponsor
- Spanish Breast Cancer Research Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-23
- Primary completion
- 2022-12-15
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.